Joint International Symposium on EBV & KSHV & Related Agents & Diseases
Join the world’s EBV and KSHV experts at the upcoming 3rd Joint International Symposium on EBV & KSHV & Related Agents & Diseases: June 29-July 3, 2024 Boston, USA. The …
Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma
As 2021 comes to a close, we celebrate some important work published by our colleagues (Ambinder, et al) who dedicate their careers to improving diagnosis, treatment and outcomes for people …
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features
The ACSR is proud to share the latest EBV/DLBCL research from the ACSR’s own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! EBV-positive HIV-associated diffuse large B cell …
EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
Using ACSR Specimens, Colm Keane et al. give us the largest in-depth description of the biology of Primary Central Nervous Lymphoma occurring in patients with AIDS. This disease demonstrates a …
International Conference on EBV & KSHV 2018
The EBV/KSHV Meeting will take place July 28 – August 1, 2018, at the Memorial Union on the University of Wisconsin-Madison campus. The overlapping DNA Tumor Viruses Meeting will be …